STUDY

Protopic ointment helped eczema more than Elidel cream

“Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies.” Paller AS et al. Journal of the American Academy of Dermatology. May 2005

Paller AS et al. · Journal of the American Academy of Dermatology · May 2005

Three randomized trials, combined reportEczemaProtopicElidel
The finding

In three 6-week trials with 1,065 people, tacrolimus ointment improved eczema more than pimecrolimus cream in adults (54% vs 35% better) and in children with moderate to severe eczema (67% vs 56%).

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized and investigator-blinded. This paper reports three studies. A random process decided who got which treatment. The doctors scoring the results did not know which one each person used.
At a glance

Who was studied and for how long

People
1,065
Adults and children
Length
6 weeks
Three studies
Condition
Mild to very severe eczema
Atopic dermatitis
Compared
Tacrolimus ointment vs pimecrolimus cream
Both non-steroid
Main score
EASI
Eczema Area and Severity Index
What they did

How the study worked

1,065 peoplemild to very severe eczemaRANDOMSPLITTacrolimusointmentRandomized group6 weeksPimecrolimuscreamRandomized group6 weeksMEASURED ATWeek 6by blinded doctors1,065 peoplemild to very severe eczemaRANDOMSPLITTacrolimus ointmentRandomized group · 6 weeksPimecrolimus creamRandomized group · 6 weeksMEASURED ATWeek 6by blinded doctors
1. Split at random1,065 people with eczema were randomly put on tacrolimus ointment or pimecrolimus cream, across three studies.
2. Same lengthEach study ran for 6 weeks.
3. Blinded scoringDoctors who did not know the treatment scored EASI, overall improvement, skin area affected, and itch.
What they found

The results

Tacrolimus ointmentPimecrolimus cream

Adults: eczema score improvement

Average EASI improvement at the end of the study

Tacrolimus
54.1%
Pimecrolimus
34.9%
Difference unlikely to be chance (p < 0.0001)

Children with moderate to severe eczema

Average EASI improvement at the end of the study

Tacrolimus
67.2%
Pimecrolimus
56.4%
Difference unlikely to be chance (p = 0.04)
Tacrolimus came out ahead in both groups, with the biggest gap in adults. Tacrolimus also worked faster and was better for itch and overall rating. Side effects were similar, though adults on tacrolimus had more skin reactions on day 1.
How much to trust it

Strengths and limits

Strengths

  • Three randomized studies with 1,065 people
  • Included both adults and children
  • Doctors scoring results did not know the treatment

Limits

  • Patients and caregivers knew which product they used, since an ointment and a cream look and feel different
  • Only 6 weeks
  • Compares the two brands' standard strengths and does not cover long-term safety
Moderate confidence. Large and consistent, but not double-blind. Better for comparing short-term results than long-term safety.
What it means for you

The takeaway

Tacrolimus did better

For eczema, tacrolimus ointment improved scores more than pimecrolimus cream over 6 weeks, especially in adults.

Ointments and creams feel different on the skin, and some people prefer one over the other. Ask your dermatologist which is better for your skin and where on the body you are using it.

Pages that cite this study

Read more on Dermapedia

Condition
Eczema
Medication
Protopic
Medication
Elidel
Terms in this study

Words worth knowing

EASI

Eczema Area and Severity Index. A score for how much skin is affected and how red, thick, and scratched it is.

Investigator-blinded

The doctors scoring results did not know which treatment each person used.

Calcineurin inhibitor

A non-steroid medicine class that calms the immune response in the skin.

p-value

A measure of how likely a difference this size would show up by chance alone. Below 0.05 is the usual cutoff for "probably real."

Original source

Paller AS, Lebwohl M, Fleischer AB, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ, US/Canada Tacrolimus Ointment Study Group. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005;52(5):810–822.

PMID 15858471